← Leaderboards
Vasily M Studitsky
Research Inst Of Fox Chase Can Ctr
$6,950,102
Attributed
$8,733,603
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $759K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,733,603 · 4
By mechanism
R01$8,298,795 · 3
R21$434,808 · 1
Top collaborators
- David J Stillman4 shared
- Siddharth Balachandran3 shared
Most similar at Research Inst Of Fox Chase Can Ctr
Same institution · by research overlap
- Siddharth Balachandran$16,302,354
Others in their field
Top investigators on “Nucleosomes”
- Craig L Peterson · Univ Of Massachusetts Med Sch Worcester$21,567,131
- Michael-Christopher Keogh · Epicypher, Inc.$20,883,986
- Charles David Allis · University Of Virginia Charlottesville$20,274,864
- Robert Kingston · Massachusetts General Hospital$19,633,019
- Zu-Wen Sun · Epicypher, Inc.$18,267,406
- Zhiguo Zhang · Mayo Clinic$16,793,507
Research focus
NucleosomesChromatinHistonesGenetic TranscriptionFluorescence Resonance Energy TransferMolecular GeneticsMolecular ChaperonesTranscriptSingle MoleculeIn VitroPositioning AttributeChromatin StructureIn VivoBiochemicalRegulationMolecularMalignant NeoplasmsTranscription ProcessPolymerasePlayProteinsTranscription InitiationGenesTranscription Factor
Grant awards (28)
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy$758,985
R01 · FY2025 · CA
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy$721,035
R01 · FY2024 · CA
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy$758,985
R01 · FY2023 · CA
Mechanism of yFACT Action during Chromatin Transcription$335,900
R01 · FY2020 · GM · contact PI
Mechanism of yFACT Action during Chromatin Transcription$330,571
R01 · FY2019 · GM · contact PI
Mechanisms of PARP-1 interaction with chromatin$142,008
R21 · FY2019 · CA · contact PI
Mechanism of yFACT Action during Chromatin Transcription$330,571
R01 · FY2018 · GM · contact PI
Mechanisms of PARP-1 interaction with chromatin$146,400
R21 · FY2018 · CA · contact PI
Mechanism of yFACT Action during Chromatin Transcription$330,955
R01 · FY2017 · GM · contact PI
Mechanisms of PARP-1 interaction with chromatin$146,400
R21 · FY2017 · CA · contact PI
Mechanism of Transcript Elongation in Chromatin by RNA Polymerase II$365,925
R01 · FY2015 · GM · contact PI
Mechanism of Transcript Elongation in Chromatin by RNA Polymerase II$365,925
R01 · FY2014 · GM · contact PI
Mechanism of Transcript Elongation in Chromatin by RNA Polymerase II$332,167
R01 · FY2013 · GM · contact PI
Mechanism of Transcript Elongation in Chromatin by RNA Polymerase II$18,309
R01 · FY2013 · GM · contact PI
Mechanism of Transcript Elongation in Chromatin by RNA Polymerase II$319,800
R01 · FY2012 · GM · contact PI
Mechanism Transcript Elongation in Chromatin$312,741
R01 · FY2010 · GM · contact PI
Mechanism Transcript Elongation in Chromatin$413,292
R01 · FY2009 · GM · contact PI
Mechanism Transcript Elongation in Chromatin$315,900
R01 · FY2009 · GM · contact PI
Mechanism Transcript Elongation in Chromatin$315,900
R01 · FY2008 · GM · contact PI
Mechanism Transcript Elongation in Chromatin$315,900
R01 · FY2007 · GM · contact PI
MECHANISM OF TRANSCRIPT ELONGATION IN CHROMATIN$262,694
R01 · FY2006 · GM · contact PI
MECHANISM OF TRANSCRIPT ELONGATION IN CHROMATIN$269,015
R01 · FY2005 · GM
MECHANISM OF TRANSCRIPT ELONGATION IN CHROMATIN$269,015
R01 · FY2004 · GM
MECHANISM OF TRANSCRIPT ELONGATION IN CHROMATIN$178,581
R01 · FY2003 · GM
MECHANISM OF TRANSCRIPT ELONGATION IN CHROMATIN$119,640
R01 · FY2003 · GM
MECHANISM OF TRANSCRIPT ELONGATION IN CHROMATIN$191,089
R01 · FY2002 · GM
MECHANISM OF TRANSCRIPT ELONGATION IN CHROMATIN$185,610
R01 · FY2001 · GM
MECHANISM OF TRANSCRIPT ELONGATION IN CHROMATIN$180,290
R01 · FY2000 · GM